e-learning
resources
Paris 2018
Tuesday, 18.09.2018
Studies on the mechanisms underlying airway disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Novel treatment of eosinophilic bronchitis with allergic fungal sinusitis using mepolizumab- One year follow-up.
Y. Takeshita (atami, Japan), S. Nobuyama (atami, Japan), Y. Kanetsuna (atami, Japan), T. Satou (atami, Japan)
Source:
International Congress 2018 – Studies on the mechanisms underlying airway disease
Session:
Studies on the mechanisms underlying airway disease
Session type:
Thematic Poster
Number:
4411
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Y. Takeshita (atami, Japan), S. Nobuyama (atami, Japan), Y. Kanetsuna (atami, Japan), T. Satou (atami, Japan). Novel treatment of eosinophilic bronchitis with allergic fungal sinusitis using mepolizumab- One year follow-up.. 4411
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Novel treatment of eosinophilic bronchitis with allergic fungal sinusitis using mepolizumab
Source: International Congress 2017 – Evolution or revolution in the treatment of asthma and allergies
Year: 2017
Asthma exacerbations and eosinophilic inflammation 6 months after treatment with mepolizumab in refractory eosinophilic asthma
Source: Annual Congress 2009 - Towards improving asthma control
Year: 2009
Idiopathic chronic eosinophilic pneumonia and asthma: how do they influence each other?
Source: Eur Respir J 2003; 22: 8-13
Year: 2003
Bronchial asthma and hyperreactivity after infantile bronchiolitis or pneumonia: a 20-year follow-up study
Source: Eur Respir J 2002; 20: Suppl. 38, 333s
Year: 2002
Treatment options in severe fungal asthma and allergic bronchopulmonary aspergillosis
Source: Eur Respir J 2014; 43: 1487-1500
Year: 2014
Clinical outcome of eosinophilic airway inflammation in chronic airway diseases including nonasthmatic eosinophilic bronchitis
Source: International Congress 2017 – Asthma and allergy: from the bench to the bedside
Year: 2017
Epinastine improves cough in eosinophilic bronchitis (atopic cough)
Source: Eur Respir J 2001; 18: Suppl. 33, 425s
Year: 2001
Role of atypical bacterial infections in exacerbation of asthma in children
Source: Eur Respir J 2005; 26: Suppl. 49, 165s
Year: 2005
Effect of anti-IL5 treatment on symptoms of chronic rhinosinusitis, otitis and hearing loss in patients with severe eosinophilic asthma
Source: International Congress 2019 – Clinical approach to asthma management
Year: 2019
Resolution of bronchial inflammation during exacerbations of chronic bronchitis relate to changes in bacteriology.
Source: Eur Respir J 2002; 20: Suppl. 38, 592s
Year: 2002
Changes in bronchial inflammation during acute exacerbations of chronic bronchitis
Source: Eur Respir J 2001; 17: 1112-1119
Year: 2001
Development of asthma in patients with eosinophilic bronchitis: prospective follow up study
Source: Eur Respir J 2002; 20: Suppl. 38, 51s
Year: 2002
Allergic inflammation markers for earlier diagnosis of bronchial asthma in patients with allergic rhinitis
Source: Annual Congress 2008 - Asthma: growing understanding of influential factors
Year: 2008
Rapid Benralizumab effectiveness in patients with severe eosinophilic asthma and bronchiectasis
Source: Virtual Congress 2020 – Monoclonal antibodies in asthma
Year: 2020
Effects of omalizumab on markers of eosinophilic inflammation in patients with severe allergic asthma
Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD
Year: 2011
Diagnosis and treatment of allergic rhinitis in asthmatic children
Source: Annual Congress 2009 - Allergic rhinitis and its impact on asthma in children
Year: 2009
Chronic paranasal sinusitis exacerbates allergic inflammation in patients with asthma and contributes to refractoriness to treatment
Source: Annual Congress 2012 - Clinical aspects and treatment of asthma and allergic respiratory diseases
Year: 2012
‘Real-life‘ persistence beyond the first year of omalizumab treatment in patients with severe allergic asthma: The R-Pixel study
Source: Annual Congress 2011 - Asthma management and response
Year: 2011
Incidence of allergic asthma in patients with sarcoidosis
Source: Eur Respir J 2006; 28: Suppl. 50, 232s
Year: 2006
Fungous infections and bronchial asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 377s
Year: 2005
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept